Cargando…
Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596649/ https://www.ncbi.nlm.nih.gov/pubmed/34803901 http://dx.doi.org/10.3389/fneur.2021.793620 |
| _version_ | 1784600432196190208 |
|---|---|
| author | Frontiers Production Office, |
| author_facet | Frontiers Production Office, |
| author_sort | Frontiers Production Office, |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8596649 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85966492021-11-18 Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus Frontiers Production Office, Front Neurol Neurology Frontiers Media S.A. 2021-11-03 /pmc/articles/PMC8596649/ /pubmed/34803901 http://dx.doi.org/10.3389/fneur.2021.793620 Text en Copyright © 2021 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neurology Frontiers Production Office, Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus |
| title | Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus |
| title_full | Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus |
| title_fullStr | Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus |
| title_full_unstemmed | Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus |
| title_short | Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus |
| title_sort | erratum: assessment of the effect of erenumab on efficacy and quality-of-life parameters in a cohort of migraine patients with treatment failure in cyprus |
| topic | Neurology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596649/ https://www.ncbi.nlm.nih.gov/pubmed/34803901 http://dx.doi.org/10.3389/fneur.2021.793620 |
| work_keys_str_mv | AT frontiersproductionoffice erratumassessmentoftheeffectoferenumabonefficacyandqualityoflifeparametersinacohortofmigrainepatientswithtreatmentfailureincyprus |